The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Phytoestrogens and Their Human Metabolites Show Distinct Agonistic and Antagonistic Properties on Estrogen Receptor (ER ) and ER in Human Cells
Open accessAbstract
Phytoestrogens exert pleiotropic effects on cellular signaling and show some beneficial effects on estrogen-dependent diseases. However, due to activation/inhibition of the estrogen receptors ERalpha or ERbeta, these compounds may induce or inhibit estrogen action and, therefore, have the potential to disrupt estrogen signaling. We performed a comprehensive analysis and potency comparison of phytoestrogens and their human metabolites for ER binding, induction/suppression of ERalpha and ERbeta transactivation, and coactivator recruitment in human cells. The soy-derived genistein, coumestrol, and equol displayed a preference for transactivation of ERbeta compared to ERalpha and were 10- to 100-fold less potent than diethylstilbestrol. In contrast, zearalenone was the most potent phytoestrogen tested and activated preferentially ERalpha. All other phytoestrogens tested, including resveratrol and human metabolites of daidzein and enterolactone, were weak ER agonists. Interestingly, the daidzein metabolites 3',4',7-isoflavone and 4',6,7-isoflavone were superagonists on ERalpha and ERbeta. All phytoestrogens tested showed reduced potencies to activate ERalpha and ERbeta compared to diethylstilbestrol on the estrogen-responsive C3 promoter compared to a consensus estrogen response element indicating a degree of promoter dependency. Zearalenone and resveratrol were antagonistic on both ERalpha and ERbeta at high doses. The phytoestrogens enhanced preferentially recruitment of GRIP1 to ERalpha similar to 17beta-estradiol. In contrast, for ERbeta no distinct preference for one coactivator (GRIP1 or SRC-1) was apparent and the overall coactivator association was less pronounced than for ERalpha. Due to their abundance and (anti)-estrogenic potencies, the soy-derived isoflavones, coumestrol, resveratrol, and zearalenone would appear to have the potential for effectively functioning as endocrine disruptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., & Gustafsson, J.-Å. (1998) · Endocrinology · doi:10.1210/endo.139.10.6216 · Cited by 4,203
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,387
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045
Self-citationThe Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling
Hall, J. M., Couse, J. F., & Korach, K. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100029200 · Cited by 1,208
Estrogen receptor interaction with estrogen response elements
Klinge, C. M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.14.2905 · Cited by 1,081
Voegel, J. J., Heine, M. J., Zechel, C., Chambon, P., & Gronemeyer, H. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00736.x · Cited by 1,079
Hall, J. M., & McDonnell, D. P. (1999) · Endocrinology · doi:10.1210/endo.140.12.7179 · Cited by 1,075
Postnatal Sex Reversal of the Ovaries in Mice Lacking Estrogen Receptors α and β
Couse, J. F., Hewitt, S. C., Bunch, D. O., Sar, M., Walker, V. R., Davis, B. J., & Korach, K. S. (1999) · Science · doi:10.1126/science.286.5448.2328 · Cited by 595
Phytoestrogens: epidemiology and a possible role in cancer protection.
Adlercreutz, H. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103s7103 · Cited by 553
Resveratrol Acts as a Mixed Agonist/Antagonist for Estrogen Receptors α and β*
Bowers, J. L., Tyulmenkov, V. V., Jernigan, S. C., & Klinge, C. M. (2000) · Endocrinology · doi:10.1210/endo.141.10.7721 · Cited by 526
Opposing Action of Estrogen Receptors α and β on Cyclin D1 Gene Expression
Liu, M.-M., Albanese, C., Anderson, C. M., Hilty, K., Webb, P., Uht, R. M., Price, R. H., Pestell, R. G., & Kushner, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201829200 · Cited by 422
Estrogen receptor (ER) modulators each induce distinct conformational changes in ER α and ER β
Paige, L. A., Christensen, D. J., Grøn, H., Norris, J. D., Gottlin, E. B., Padilla, K. M., Chang, C.-Y., Ballas, L. M., Hamilton, P. T., McDonnell, D. P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3999 · Cited by 412
Phyto-oestrogens: where are we now?
Bingham, S. A., Atkinson, C., Liggins, J., Bluck, L., & Coward, A. (1998) · British Journal of Nutrition · doi:10.1079/bjn19980068 · Cited by 393
Differential Effects of Xenoestrogens on Coactivator Recruitment by Estrogen Receptor (ER) α and ERβ
Routledge, E. J., White, R., Parker, M. G., & Sumpter, J. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006777200 · Cited by 362
Nishikawa, J.-I., Saito, K., Goto, J., Dakeyama, F., Matsuo, M., & Nishihara, T. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8557 · Cited by 331
Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat, K., Lantvit, D. D., Christov, K. T., Mehta, R. G., Moon, R. C., & Pezzuto, J. M. (2001) · PubMed · Cited by 330
An, J., Tzagarakis-Foster, C., Scharschmidt, T. C., Lomri, N., & Leitman, D. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100953200 · Cited by 323
Murrill, W. B., Brown, N. M., Zhang, J.-X., Manzolillo, P. A., Barnes, S., & Lamartiniere, C. A. (1996) · Carcinogenesis · doi:10.1093/carcin/17.7.1451 · Cited by 322
Isoflavones, lignans and stilbenes - origins, metabolism and potential importance to human health
Cassidy, A., Hanley, B., & Lamuela-Raventos, R. M. (2000) · Journal of the Science of Food and Agriculture · doi:10.1002/(sici)1097-0010(20000515)80:7<1044::aid-jsfa586>3.0.co;2-n · Cited by 313
Uterine adenocarcinoma in mice treated neonatally with genistein.
Newbold, R. R., Padilla‐Banks, E., Bullock, B. C., & Jefferson, W. N. (2001) · PubMed · Cited by 275
Soy Isoflavones: a Safety Review
Munro, I. C., Harwood, M., Hlywka, J. J., Stephen, A. M., Doull, J., Flamm, W. G., & Adlercreutz, H. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.janr.1-33 · Cited by 265
Hall, J. M. (2002) · Molecular Endocrinology · doi:10.1210/me.16.3.469 · Cited by 253
ICI 182,780, a new antioestrogen with clinical potential
Wakeling, A. E., & Bowler, J. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90204-v · Cited by 242
Molecular mechanism of the chemopreventive effect of resveratrol
Dong, Z. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00330-5 · Cited by 227
Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats
Delclos, K. B., Bucci, T. J., Lomax, L. G., Latendresse, J. R., Warbritton, A., Weis, C. C., & Newbold, R. R. (2001) · Reproductive Toxicology · doi:10.1016/s0890-6238(01)00177-0 · Cited by 208
Allred, C. D. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1667 · Cited by 194
Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis
Hilakivi-Clarke, L., Onojafe, I., Raygada, M., Cho, E., Skaar, T., Russo, I., & Clarke, R. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690584 · Cited by 186
Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol
Basly, J.-P., Marre-Fournier, F., Le Bail, J.-C., Habrioux, G., & Chulia, A. J. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00650-5 · Cited by 179
Hilakivi-Clarke, L., Cho, E., Onojafe, I., Raygada, M., & Clarke, R. (1999) · Oncology Reports · doi:10.3892/or.6.5.1089 · Cited by 177
Dual effects of phytoestrogens result in u-shaped dose-response curves.
Almstrup, K., Fernández, M. F., Petersen, J. H., Olea, N., Skakkebaek, N. E., & Leffers, H. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110743 · Cited by 161
Genistein: does it prevent or promote breast cancer?
Bouker, K. B., & Hilakivi-Clarke, L. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108701 · Cited by 160
Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout mice
Mueller, S. O., & Korach, K. S. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00105-9 · Cited by 157
Self-citationFan, J. D., Wagner, B. L., & McDonnell, D. P. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.12.8961270 · Cited by 139
Mazur, W., & Adlercreutz, H. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00333-6 · Cited by 137
Genistein blocks breast cancer cells in the G2M phase of the cell cycle
Cappelletti, V., Fioravanti, L., Miodini, P., & di Fronzo, G. (2000) · Journal of Cellular Biochemistry · Cited by 135
Overview of in vitro tools to assess the estrogenic and antiestrogenic activity of phytoestrogens
Mueller, S. O. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00282-9 · Cited by 124
Self-citationBhat, K., & Pezzuto, J. M. (2001) · PubMed · Cited by 119
Mueller, S. O., Kling, M., Firzani, P. A., Mecky, A., Duranti, E., Shields-Botella, J., Delansorne, R., Broschard, T. H., & Kramer, P.-J. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(03)00016-x · Cited by 115
Self-citationPhytoestrogens: Epidemiology and a Possible Role in Cancer Protection
Adlercreutz, H. (1995) · Environmental Health Perspectives · doi:10.2307/3432518 · Cited by 114
Identification of a Third Autonomous Activation Domain within the Human Estrogen Receptor
Norris, J. D., Fan, D., Kerner, S. A., & McDonnell, D. P. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.6.0008 · Cited by 113
Hall, J. M., & Korach, K. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200849200 · Cited by 100
Genistein action in the prepubertal mammary gland in a chemoprevention model
Cotroneo, M. S., Wang, J., Fritz, W. A., Eltoum, I.-E., & Lamartiniere, C. A. (2002) · Carcinogenesis · doi:10.1093/carcin/23.9.1467 · Cited by 93
Novel metabolites of the mammalian lignans enterolactone and enterodiol in human urine
Jacobs, E., Kulling, S. E., & Metzler, M. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00033-3 · Cited by 70
Potential tissue selectivity of dietary phytoestrogens and estrogens
Cassidy, A. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199902000-00009 · Cited by 68
Potential endocrine-modulating effects of various phytoestrogens in the diet
Jefferson, W. N., & Newbold, R. R. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00306-3 · Cited by 63
Jacobs, E. J., & Metzler, M. (1999) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9809176 · Cited by 60
Coregulators of Estrogen Receptor Action
Tremblay, G. B., & Giguère, V. (2002) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.v12.i1.10 · Cited by 52
Oxidative Metabolites of the Mammalian Lignans Enterodiol and Enterolactone in Rat Bile and Urine
Niemeyer, H. B., Honig, D. M., Lange-Böhmer, A., Jacobs, E. J., Kulling, S. E., & Metzler, M. (2000) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0000530 · Cited by 50
Mueller, S. O., Hall, J. M., Swope, D. L., Pedersen, L. C., & Korach, K. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m203578200 · Cited by 37
Self-citation
Cited by
Masella, R., Di Benedetto, R., Varì, R., Filesi, C., & Giovannini, C. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.05.013 · Cited by 1,107
Křížová, L., Dadáková, K., Kašparovská, J., & Kašparovský, T. (2019) · Molecules · doi:10.3390/molecules24061076 · Cited by 692
Anti-cancer potential of flavonoids: recent trends and future perspectives
Batra, P., & Sharma, A. K. (2013) · 3 Biotech · doi:10.1007/s13205-013-0117-5 · Cited by 550
Adlercreutz, H. (2007) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360701612942 · Cited by 547
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging
Simioni, C., Zauli, G., Martelli, A. M., Vitale, M., Sacchetti, G., Gonelli, A., & Neri, L. M. (2018) · Oncotarget · doi:10.18632/oncotarget.24729 · Cited by 518
Metadata
- Authors
- Mueller, S. O.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-03-10
- Volume
- 80
- Issue
- 1
- Pages
- 14-25
- ISSN
- 1096-0929 (ISSN-L)
- OpenAlex
- W2103513010
- Cited by
- 547
- References
- 50
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.